Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v3-EN
Language English English
Date Updated 2023-08-09 2023-08-08
Drug Identification Number 02423235 02423235
Brand name JAMP-EZETIMIBE JAMP-EZETIMIBE
Common or Proper name Ezetimibe Tablets, USP Ezetimibe Tablets, USP
Company Name JAMP PHARMA CORPORATION JAMP PHARMA CORPORATION
Ingredients EZETIMIBE EZETIMIBE
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C10AX C10AX
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2023-05-10 2023-05-10
Estimated end date 2023-08-18 2023-08-18
Actual end date 2023-08-08 2023-08-08
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Disruption of the manufacture of the drug. Blister 3x10 available under allocation. Disruption of the manufacture of the drug. Blister 3x10 available under allocation.
Health Canada comments